Statement in response to The Times of London report on 20 May 2017 on Florinef
Having noted the report published in The Times of London on 20 May 2017 titled “Massive price rise for vital drug put pets’ lives at
Opening of European Commission proceedings
Aspen confirms that the European Commission has opened proceedings to investigate certain actions of Aspen Holdings and certain of its European subsidiaries. While Aspen is
Aspen’s response to the reported Competition Commission investigation
Durban – Media reports that the Competition Commission has decided to take up the Democratic Alliance’s request to investigate the alleged anti-competitive conduct of Aspen
Statement in response to press reports of 14 and 15 April 2017
In reference to the articles reported in the European press on 14 and 15 April 2017, Aspen Pharmacare Holdings Limited (“Aspen”) has the following comments:
Honouring Ahmed M Kathrada
This morning we wake up to the news, that one of the country’s foremost leaders, a true son of the African soil, Ahmed Mohammed Kathrada,
Aspen’s half-year revenue increases 13% to R19.8 billion
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading pharmaceutical company in the southern hemisphere, has announced favourable results for the six
Stephen Saad receives the coveted CNBC Africa Entrepreneur of the Year Award
Stephen Saad’s acceptance speech for the Entrepreneur of the Year Award at AABLA.
Stephen Saad scoops Entrepreneur of the Year Award
Johannesburg. Stephen Saad, Aspen Group Chief Executive, was announced as the winner of the Entrepreneur of the Year Award at the All Africa Business Leaders
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
